Regeneron (REGN) Tops Q3 EPS by 132c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $805.97 --0%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.14, $1.32 better than the analyst estimate of $9.82. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.94 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
